{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:54:52Z","timestamp":1792814092921,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the clinical effects between dexamethasone and triamcinolone acetonide (TA) after phacoemulsification and intraocular lens implantation among cataract patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Pubmed, Embase, and the Cochrane Library were searched for studies published up to August 2020. The primary outcome was intraocular pressure. The secondary outcomes were the logarithm of the minimum angle of resolution (logMAR), anterior chamber cell, and anterior chamber flare. The pooled effect sizes were expressed as weighted mean differences (WMDs) or standardized mean differences (SMDs) of 95% confidence intervals (95% CIs). Cochrane Collaboration risk of bias tool and Newcastle-Ottawa scale criteria were used for the quality assessment of included studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seven relevant studies met the inclusion criteria. For the primary outcome, there was no significant difference between TA injection and dexamethasone in comparing intraocular pressure (IOP) (SMD\u2005=\u20050.22, 95% confidence interval [CI] [\u22120.29, 0.73], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.408; I\u00b2\u2005=\u200586.9%) in the first day after treatment and last day of assessment. For the secondary outcomes, the logMAR (WMD\u2005=\u20050.01, 95% CI [\u22120.06, 0.08]) and the anterior chamber flare (SMD\u2005=\u20050.08, 95% CI [\u22120.01, 0.18], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.087; I\u00b2\u2005=\u20050%) showed no differences. However, the amount of anterior chamber cells (SMD\u2005=\u2005\u22120.21, 95% CI [\u22120.42, \u22120.01], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.044; I\u00b2\u2005=\u20050%) in the TA injection on the first day postoperative was higher than for dexamethasone. After treatment, there was no difference between the 2 groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study supports that there were no differences in IOP, logMAR, and anterior chamber flare between TA injection and dexamethasone among cataract patients. TA injection treatment on the first day showed higher amounts of anterior chamber cells than with dexamethasone.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037584","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:07:26Z","timestamp":1717769246000},"page":"e37584","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of the efficacy between dexamethasone versus triamcinolone acetonide after cataract surgery: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-8751","authenticated-orcid":false,"given":"Tianqiu","family":"Zhou","sequence":"first","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Kang","sequence":"additional","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijin","family":"Guan","sequence":"additional","affiliation":[{"name":"Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"e112054","DOI":"10.1371\/journal.pone.0112054","article-title":"Age-related cataract, cataract surgery and subsequent mortality: a systematic review and meta-analysis.","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"15014","DOI":"10.1038\/nrdp.2015.14","article-title":"Cataract.","volume":"1","author":"Lam","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pop.2015.05.012","article-title":"Cataracts.","volume":"42","author":"Thompson","year":"2015","journal-title":"Prim Care"},{"key":"R4-20250503","first-page":"58","article-title":"The evolution of cataract surgery.","volume":"113","author":"Davis","year":"2016","journal-title":"Mo Med"},{"key":"R5-20250503","first-page":"317","article-title":"Clinical comparison of submucosal injection of dexamethasone and triamcinolone acetonide on postoperative discomfort after third molar surgery.","volume":"46","author":"Zerener","year":"2015","journal-title":"Quintessence Int"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/0301-4738.156945","article-title":"Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.","volume":"63","author":"Ozge","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4103\/0301-4738.141045","article-title":"Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.","volume":"62","author":"Gungor","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/DDDT.S66611","article-title":"Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.","volume":"8","author":"Dang","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/jop.2019.0072","article-title":"Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery.","volume":"35","author":"Grzybowski","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jcrs.2018.05.015","article-title":"Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED study report 2.","volume":"44","author":"Wielders","year":"2018","journal-title":"J Cataract Refract Surg"},{"key":"R11-20250503","first-page":"125","article-title":"[Triamcinolone acetonide in the treatment of inflammation after cataract surgery].","volume":"60","author":"Lacmanovi\u0107 Loncar","year":"2006","journal-title":"Acta Med Croatica"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/aos.13670","article-title":"Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination.","volume":"96","author":"Ylinen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1381612822666161129150628","article-title":"Dropless cataract surgery: an overview.","volume":"23","author":"Lindstrom","year":"2017","journal-title":"Curr Pharm Des"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00565011","article-title":"Duration of action of depot-corticosteroids. II. Triamcinolone acetonide and triamcinolone diacetate.","volume":"3","author":"Frey","year":"1971","journal-title":"Eur J Clin Pharmacol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5301\/ejo.5000768","article-title":"Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.","volume":"26","author":"Costa","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/rej.2018.2141","article-title":"Combination of grid laser photocoagulation and a single intravitreal ranibizumab as an efficient and cost-effective treatment option for macular edema secondary to branch retinal vein occlusion.","volume":"22","author":"Cao","year":"2019","journal-title":"Rejuvenation Res"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/aos.14175","article-title":"Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery.","volume":"98","author":"Lindholm","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12886-019-1131-0","article-title":"Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.21037\/apm-21-3274","article-title":"Efficacy and safety of triamcinolone acetonide injection combined with laser photocoagulation in the treatment of diabetic macular edema: a systematic review and meta-analysis.","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/IAE.0000000000000284","article-title":"Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection.","volume":"35","author":"Siqueira","year":"2015","journal-title":"Retina"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09273948.2018.1501492","article-title":"A comparison of the dexamethasone implant (Ozurdex\u00ae) and inferior fornix-based sub-tenon triamcinolone acetonide for treatment of inflammatory ocular diseases.","volume":"27","author":"Errera","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1442-9071.2011.02504.x","article-title":"Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.","volume":"39","author":"Sheth","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3928\/23258160-20160229-05","article-title":"A comparison of intraoperative dexamethasone intravitreal implant and triamcinolone acetonide used during vitrectomy and epiretinal membrane peeling: a case control study.","volume":"47","author":"Yonekawa","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop.","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.310.6993.1481","article-title":"Reliability of the Snellen chart.","volume":"310","author":"McGraw","year":"1995","journal-title":"BMJ"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcrs.2013.04.042","article-title":"Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy.","volume":"39","author":"Wang","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R28-20250503","first-page":"1757","article-title":"Two different chemoprophylaxis approaches after phacoemulsification surgery in one thousand patients in Iraq.","volume":"18","author":"Rattan","year":"2018","journal-title":"Int Eye Sci"},{"key":"R29-20250503","first-page":"819","article-title":"Effects of intracameral triamcinolone and gentamicin injections following cataract surgery.","volume":"94","author":"Simaroj","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"R30-20250503","first-page":"1127","article-title":"Comparison of the safety and efficacy of single injection of subtenon triamcinolone and topical dexamethasone in reducing postoperative inflammation after phacoemulsification and intraocular lens implantation.","volume":"66","author":"Khan","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"R31-20250503","first-page":"e7592","article-title":"Intracameral triamcinolone acetonide versus topical dexamethasone: a comparison of anti-inflammatory effects after phacoemulsification.","volume":"12","author":"Haider Shaheen","year":"2020","journal-title":"Cureus"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.survophthal.2006.02.006","article-title":"A review of anterior segment dysgeneses.","volume":"51","author":"Idrees","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bjo.76.11.681","article-title":"Pharmacokinetics of ophthalmic corticosteroids.","volume":"76","author":"McGhee","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/eye.2009.182","article-title":"Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery.","volume":"24","author":"Karalezli","year":"2010","journal-title":"Eye (Lond)"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0420.2007.01114.x","article-title":"Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.","volume":"86","author":"Karalezli","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jcrs.2010.03.040","article-title":"Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes.","volume":"36","author":"Dixit","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jcrs.2010.04.038","article-title":"Intracameral triamcinolone acetonide after pediatric cataract surgery.","volume":"36","author":"Cleary","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/02713683.2016.1214968","article-title":"Comparison of dexamethasone intravitreal implant with conventional triamcinolone in patients with postoperative cystoid macular edema.","volume":"42","author":"Mylonas","year":"2017","journal-title":"Curr Eye Res"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40942-018-0114-2","article-title":"Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.","volume":"4","author":"Mishra","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"4857696","DOI":"10.1155\/2022\/4857696","article-title":"Comparative outcomes of standard perioperative eye drops, intravitreal triamcinolone acetonide-moxifloxacin, and intracameral dexamethasone-moxifloxacin-ketorolac in cataract surgery.","volume":"2022","author":"Kuriakose","year":"2022","journal-title":"J Ophthalmol"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00417-022-05852-x","article-title":"Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.","volume":"261","author":"Hsieh","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:26:26Z","timestamp":1746318386000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":42,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037584","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}